Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
Published Online: 2020-06-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: A Dev•A Mahipal•A R He•Aiwu Ruth He•B George•B-Y Ryoo•Baek-Yeol Ryoo•Bo Liu•C-H Hsu•Chih-Hung Hsu•D Ryan•E Gane•G Manji•H C Chung•H Hochster•Heba Abdullah•J Bendell•J Lee•J Strickler•J-S Chen•Jessica Spahn•K Numata•Kazushi Numata•Kyung-Hun Lee•M Ikeda•M Lee•M Morimoto•M Pishvaian•Michael S Lee•N Sasahira•N Tebbutt•S L Davis•S Qin•S Stein•Stacey Stein•Stephen P Hack•Wendy Verret•Y Chao•Y-J Bang•Yulei Wang
